These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Epigenetic-related therapeutic challenges in cardiovascular disease. Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254 [TBL] [Abstract][Full Text] [Related]
10. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications. Lu J; Huang Y; Zhang X; Xu Y; Nie S Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232 [TBL] [Abstract][Full Text] [Related]
11. The epigenetic landscape of exercise in cardiac health and disease. Wu G; Zhang X; Gao F J Sport Health Sci; 2021 Dec; 10(6):648-659. PubMed ID: 33333247 [TBL] [Abstract][Full Text] [Related]
12. Decoding liver injury: A regulatory role for histone modifications. Tian W; Xu Y Int J Biochem Cell Biol; 2015 Oct; 67():188-93. PubMed ID: 25801055 [TBL] [Abstract][Full Text] [Related]
13. The impact of epigenetics on cardiovascular disease. Prasher D; Greenway SC; Singh RB Biochem Cell Biol; 2020 Feb; 98(1):12-22. PubMed ID: 31112654 [TBL] [Abstract][Full Text] [Related]
15. Multiple levels of epigenetic control for bone biology and pathology. Montecino M; Stein G; Stein J; Zaidi K; Aguilar R Bone; 2015 Dec; 81():733-738. PubMed ID: 25865577 [TBL] [Abstract][Full Text] [Related]
16. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. Chistiakov DA; Orekhov AN; Bobryshev YV Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis. Ghayor C; Weber FE Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598138 [TBL] [Abstract][Full Text] [Related]
19. Histone methylation and transcriptional regulation in cardiovascular disease. Xu Y; Fang F Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):89-97. PubMed ID: 24801729 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases. Schiano C; Benincasa G; Franzese M; Della Mura N; Pane K; Salvatore M; Napoli C Pharmacol Ther; 2020 Jun; 210():107514. PubMed ID: 32105674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]